Strengthening partnerships among health care systems and other sectors
of society (governmental and nongovernmental organizations in the area of respiratory
medicine, international institutions, environment protection agencies, industry, and
schools);
Developing globally accepted criteria for the diagnosis of CRDs;
Integrating CRD prevention into a comprehensive noncommunicable diseases
prevention programme based on the commonality of risk factors and preventive approaches;
Development and evaluation of reproducible and inexpensive methodologies
to monitor COPD suitable for use in developing countries;
Identifying and addressing barriers to drug and essential device
accessibility, developing approaches to improve accessibility to essential drugs in low
income countries, designing and implementing a study of CRD drug and device availability
and pricing in low and middle income countries;
Identifying gaps in existing guidelines, using methodologies for
guideline development that are evidence-based and take into account public health
considerations like cost-effectiveness and feasibility specially in developing countries,
using the newly developed guidelines as the rational basis for inclusion of drugs into the
Essential Drugs List;
Strengthening research on primary and secondary prevention interventions
of CRD;
Identifying research priorities, which should include in addition to
prevention strategies, therapeutic regimens, alternative drug delivery systems,
traditional medicine and alternative therapeutic approaches;
Establishment and promotion of partnerships with professional,
scientific, and educational institutions to promote and implement the initiative.
Initiating cost-effectiveness studies related to risk factor reduction and secondary
prevention interventions for CRDs with emphasis on extending the capacity of health
professionals beyond the traditional focus on acute care of communicable respiratory
diseases;
Adapting existing guidelines for the prevention and management of CRDs
to the needs of developing countries and adapting them into primary health care. The use
of single disease guidelines may become impractical in primary care settings characterised
by a heavy daily workload. The feasibility of the syndromic approach addressing common
respiratory symptoms should be explored;
Improving the capacity of health systems in responding to the health
care needs of CRDs. Affordable standards of health care for people with CRDs should be
accessible to all populations. Health care providers should have access to equipment and
supplies needed for diagnosis and management, and patients need access to essential drugs.
The role of care providers in promoting prevention measures like tobacco cessation,
immunisation, and management of acute lower respiratory tract infection and tuberculosis
should be strengthened.Secondary and tertiary prevention to strengthen health care for
people with Chronic Respiratory Diseases by identifying cost-effective interventions,
upgrading standards and accessibility of care at different levels of the health care
system.
General principles |
|
|
|
